AGREEMENT AND PLAN OF MERGER by and among CLEVELAND BIOLABS, INC., HIGH STREET ACQUISITION CORP. and CYTOCOM, INC. dated as of October 16, 2020Merger Agreement • October 19th, 2020 • Cleveland Biolabs Inc • Services-commercial physical & biological research • Delaware
Contract Type FiledOctober 19th, 2020 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of October 16, 2020, by and among Cleveland BioLabs, Inc., a Delaware corporation (“CBLI”), High Street Acquisition Corporation, a Delaware corporation and wholly owned Subsidiary of CBLI (“Merger Sub”), and Cytocom, Inc., a Delaware corporation (“CYTO”).